Timeline
Jeanne Chiaravalli
Research Engineer
01 Aug 2025
publication
Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4
Read more02 Dec 2024
publication
High Content Screening Assay of Inhibitors of the Legionella Pneumophila Histone Methyltransferase RomA in Infected Cells.
Read more21 Jun 2024
publication
High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors.
Read more21 Apr 2023
publication
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.
Read more22 Mar 2023
04 Jul 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Read more17 Jun 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Read more01 May 2022
publication
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.
Read more21 Sep 2021
publication
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
Read more01 Sep 2021
publication
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Read more25 May 2021
publication
Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.
Read more05 Jun 2015